IDH1 and astrocytoma (excluding glioblastoma): The study also evaluated cases of mutant IDH and 1p/19q codeleted oligodendrogliomas, mutant IDH astrocytoma, wild-type IDH astrocytoma, and wild-type IDH GBMs.